Tema Etfs LLC Buys Shares of 5,912 Intuitive Surgical, Inc. $ISRG

Tema Etfs LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 5,912 shares of the medical equipment provider’s stock, valued at approximately $2,644,000.

Other institutional investors also recently added to or reduced their stakes in the company. IronOak Wealth LLC. bought a new stake in shares of Intuitive Surgical during the second quarter valued at approximately $1,099,000. Amalgamated Bank lifted its holdings in shares of Intuitive Surgical by 2.2% in the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after purchasing an additional 1,772 shares in the last quarter. Eastover Investment Advisors LLC increased its stake in Intuitive Surgical by 204.8% during the 2nd quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock valued at $7,153,000 after purchasing an additional 8,844 shares in the last quarter. SteelPeak Wealth LLC raised its holdings in Intuitive Surgical by 28.7% during the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock worth $18,781,000 after buying an additional 9,364 shares during the last quarter. Finally, Bessemer Group Inc. lifted its stake in shares of Intuitive Surgical by 89.3% in the second quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock valued at $428,386,000 after buying an additional 371,806 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Stock Performance

ISRG opened at $572.74 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm has a 50-day moving average of $566.53 and a 200 day moving average of $511.65. The firm has a market cap of $205.32 billion, a P/E ratio of 75.76, a PEG ratio of 4.77 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the previous year, the company earned $1.84 earnings per share. The company’s quarterly revenue was up 22.9% on a year-over-year basis. Equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the sale, the executive vice president directly owned 3,056 shares of the company’s stock, valued at $1,772,480. This represents a 81.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, SVP Mark Brosius sold 464 shares of the stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $548.49, for a total value of $254,499.36. Following the sale, the senior vice president directly owned 131 shares in the company, valued at $71,852.19. This trade represents a 77.98% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 114,007 shares of company stock worth $63,533,844 in the last ninety days. 0.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Raymond James Financial set a $603.00 price target on shares of Intuitive Surgical and gave the company an “outperform” rating in a research report on Wednesday, October 22nd. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 24th. Sanford C. Bernstein restated an “outperform” rating and issued a $740.00 target price (up previously from $700.00) on shares of Intuitive Surgical in a report on Friday. Royal Bank Of Canada increased their price target on Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. Finally, Wells Fargo & Company raised their price objective on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research note on Friday, December 12th. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $622.17.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.